Recently a new variant of SARS-CoV-2 was reported from South Africa. World Health
Organization (WHO) named this mutant as a variant of concern–Omicron (B. 1.1. 529) on …

Messenger RNA (mRNA) vaccine development for preventive and therapeutic applications
has evolved rapidly over the last decade. The mRVNA vaccine has proven therapeutic …

Abstract Late in 2019, SARS-CoV-2 (severe acute respiratory syndrome coronavirus-2)
emerged, causing an unknown type of pneumonia today called coronaviruses disease 2019 …

Since its emersion, coronavirus disease 2019 (COVID‐19) has been a significant global
dilemma. Several mutations in the severe acute respiratory virus (SARS‐Co‐2) genome has …

SUMMARY The SARS-CoV-2 Omicron variant (B. 1.1. 529) has been the most recent variant
of concern (VOC) established by the World Health Organization (WHO). Because of its …

The Omicron subvariants of SARS-CoV-2 have multiple mutations in the S-proteins and
show high transmissibility. We previously reported that tea catechin (−)-epigallocatechin …

Abstract Coronavirus disease 2019 (COVID‐19) is caused by severe acute respiratory
syndrome coronavirus‐2 (SARS‐CoV‐2), a highly infectious agent associated with …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs)
continue to wreak havoc across the globe. Higher transmissibility and immunologic …

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) with high infectivity, pathogenicity, and variability, is a global …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak, which
started in late 2019, drove the scientific community to conduct innovative research to contain …